Glycogen synthase kinase 3 (GSK-3) activity has been shown to be higher in insulin resistant tissues, thus causing impaired insulin action, and further resulting in high expression of glycogen synthase in diabetes [45]. The gene discussed is INS; the disease is diabetes mellitus.